EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Genotype‐Guided Asthma Treatment Reduces Exacerbations in Children: Meta‐Analysis of Two Randomized Control Trials

Elise M A Slob iD, Susanne J H Vijverberg, Tom Ruffles, Lieke C E Noij, Jacqueline Biermann, Alwin F J Brouwer, Kristel van den Brink, Annette de Bruin-Kok, Bart E Van Ewijk, Eric Haarman, Sanne C Hammer, Simone Hashimoto und 26 weitere

Allergy · 2025

DOI: 10.1111/all.16438 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Allergy, 2025. Verfasst von Elise M A Slob und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, AmsterdamUMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Asthma, Genotype, Anti-Asthmatic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Henry Smith Charity, Lung Foundation Netherlands.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long‐acting beta2‐agonists (LABA) in combination with inhaled corticosteroids (ICS) are commonly used to treat asthma, however, some children lack response to the addition of LABA. This might be partially due to the presence of the Arg16Gly polymorphism, encoded by rs1042713 G>A in the ADRB2 gene. Carrying the A allele (Arg16) at this variant has been associated with an increased risk of exacerbations despite LABA treatment. We investigated whether genotype‐guided treatment improved asthma‐related outcomes.

Methods

We conducted an individual participant data meta‐analysis of two randomised controlled trials: PUFFIN (Dutch and Swiss 6–18 year‐olds) and PACT (English and Scottish 12–18 year‐olds). Children with uncontrolled asthma despite ICS who required a step‐up in treatment were included. Participants were randomised to genotype‐guided treatment or the control group with a follow‐up of at least 6 months. Genotype‐guided treatment consisted of adding LABA for children with ADRB2 Gly16/Gly16, whilst children with ADRB2 Arg16/Arg16 or Arg16/Gly16 were treated with double dose ICS (PUFFIN) or add‐on montelukast (PACT). The primary outcome was a change in asthma control; secondary outcomes included exacerbation rate and time to exacerbation. Repeated measures mixed models and Cox regression were used.

Results

Fifty‐nine out of 102 (PUFFIN) and 59 out of 91 (PACT) children had at least one Arg (A allele). Amongst all 193 children, no difference was observed in asthma control between the study groups. However, genotype‐guided treatment resulted in lower asthma exacerbation rates (−0.08 (95%CI −0.16 to −0.00, p = 0.04)) compared to the control group.

Conclusion

Genotype‐guided step‐up treatment for children with uncontrolled asthma on ICS may lower asthma exacerbation rates and may be useful for personalising asthma care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaGenotypeAnti-Asthmatic AgentsHumansChildAdolescentReceptors, Adrenergic, beta-2Randomized Controlled Trials as TopicTreatment OutcomeMaleFemaleAdrenergic beta-2 Receptor AgonistsDisease ProgressionAlleles

Stichwörter der Autor:innen

ADRB2asthmalong‐acting beta2‐agonistpaediatricspharmacogenetics

Substanzen

Receptors, Adrenergic, beta-2Anti-Asthmatic AgentsAdrenergic beta-2 Receptor AgonistsADRB2 protein, human

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, AmsterdamUMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Clinical Pharmacy, Haaglanden Medical Center, The Hague, The Netherlands.
  • Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Academic Department of Paediatrics, Royal Alexandra Children's Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
  • Brighton and Sussex Medical School, Brighton, UK.
  • Department of Pediatric Pulmonology & Allergy, AmsterdamUMC, Emma Children's Hospital, Amsterdam, The Netherlands.

ORCID-Profile: Elise M A Slob, Christina J Jones, Steve Turner

Förderung

  • Henry Smith Charity
  • Lung Foundation Netherlands

Zitieren

APA

Slob, E. M. A., Vijverberg, S. J. H., Ruffles, T., Noij, L. C. E., Biermann, J., Brouwer, A. F. J., van den Brink, K., de Bruin-Kok, A., Van Ewijk, B. E., Haarman, E., Hammer, S. C., Hashimoto, S., Hogarth, F., Jones, C. J., Kamps, A. W. A., Kersten, E. T. G., de Kleer, I., Lipworth, B. J., Littleford, R., …, & Maitland-van der Zee, A. H. (2025). Genotype‐Guided Asthma Treatment Reduces Exacerbations in Children: Meta‐Analysis of Two Randomized Control Trials. Allergy. https://doi.org/10.1111/all.16438

Vancouver

Slob EMA, Vijverberg SJH, Ruffles T, Noij LCE, Biermann J, Brouwer AFJ, et al. Genotype‐Guided Asthma Treatment Reduces Exacerbations in Children: Meta‐Analysis of Two Randomized Control Trials. Allergy. 2025. doi:10.1111/all.16438

BibTeX
@article{Slob2025,
  author = {Slob, Elise M A and Vijverberg, Susanne J H and Ruffles, Tom and Noij, Lieke C E and Biermann, Jacqueline and Brouwer, Alwin F J and van den Brink, Kristel and de Bruin-Kok, Annette and Van Ewijk, Bart E and Haarman, Eric and Hammer, Sanne C and Hashimoto, Simone and Hogarth, Fiona and Jones, Christina J and Kamps, Arvid W A and Kersten, Elin T G and de Kleer, Ismé and Lipworth, Brian J and Littleford, Roberta and Mérelle, Marieke and Moeller, Alexander and Palmer, Colin N A and Pilvinyte, Kristina and Rutjes, Niels W and van Schaik, Ron H N and Smith, Helen E and Tavendale, Roger and Terheggen-Lagro, Suzanne W J and Turner, Steve and Twisk, Jos W R and Vaessen-Verberne, Anja and Verwaal, Mariël and de Vries, Tjalling and Wesseling, Judit and Pijnenburg, Mariëlle W and Koppelman, Gerard H and Mukhopadhyay, Somnath and Maitland-van der Zee, Anke H},
  title = {Genotype‐Guided Asthma Treatment Reduces Exacerbations in Children: Meta‐Analysis of Two Randomized Control Trials},
  journal = {Allergy},
  year = {2025},
  doi = {10.1111/all.16438}
}
Kostenlos starten →